Identification of potential biomarkers for idiopathic pulmonary fibrosis and validation of <i>TDO2</i> as a potential therapeutic target.

Wang, Ru; Yang, Yan-Mei

Identification of potential biomarkers for idiopathic pulmonary fibrosis and validation of TDO2 as a potential therapeutic target.

Wang, Ru; Yang, Yan-Mei.

Afiliação

Wang R; Henan University of Chinese Medicine, Collaborative Innovation Centre for Chinese Medicine and Respiratory Diseases, Zhengzhou 450046, Henan Province, China.
Yang YM; Zhengzhou University, Research Centre of Basic Medicine, Academy of Medical Sciences, Zhengzhou 450000, Henan Province, China. yang_yanmei@gs.zzu.edu.cn.

World J Cardiol ; 15(6): 293-308, 2023 Jun 26.

Article em En | MEDLINE | ID: mdl-37397828

Palavras-chave

Idiopathic pulmonary fibrosis; Lung function; Overall survival; TDO2 inhibitor; Transforming growth factor-ß

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China